Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Open in Screener

INCY

Incyte Corp.

May 10 • 03:50PM ET

53.10

Dollar change -0.40
Percentage change -0.75	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VOO VO USMV VUG IVV RSP IBB VOT VHT

Index	S&P 500	P/E	16.12	EPS (ttm)	3.29	Insider Own	1.20%	Shs Outstand	224.29M	Perf Week	-1.23%
Market Cap	11.92B	Forward P/E	10.60	EPS next Y	5.01	Insider Trans	-0.34%	Shs Float	221.85M	Perf Month	-3.31%
Income	745.44M	PEG	0.72	EPS next Q	1.07	Inst Own	99.66%	Short Float	4.34%	Perf Quarter	-7.91%
Sales	3.77B	P/S	3.16	EPS this Y	18.29%	Inst Trans	0.60%	Short Ratio	5.06	Perf Half Y	-1.78%
Book/sh	24.02	P/B	2.21	EPS next Y	20.08%	ROA	11.53%	Short Interest	9.64M	Perf Year	-16.93%
Cash/sh	17.15	P/C	3.10	EPS next 5Y	22.50%	ROE	15.13%	52W Range	50.27 - 67.36	Perf YTD	-15.43%
Dividend Est.	-	P/FCF	15.08	EPS past 5Y	38.99%	ROI	13.75%	52W High	-21.18%	Beta	0.73
Dividend TTM	-	Quick Ratio	3.43	Sales past 5Y	14.55%	Gross Margin	91.46%	52W Low	5.63%	ATR (14)	1.21
Dividend Ex-Date	-	Current Ratio	3.47	EPS Y/Y TTM	127.87%	Oper. Margin	18.91%	RSI (14)	44.00	Volatility	1.85% 2.34%
Employees	2524	Debt/Eq	0.01	Sales Y/Y TTM	8.58%	Profit Margin	19.78%	Recom	2.00	Target Price	72.01
Option/Short	Yes / Yes	LT Debt/Eq	0.01	EPS Q/Q	675.68%	Payout	0.00%	Rel Volume	0.57	Prev Close	53.50
Sales Surprise	-4.45%	EPS Surprise	-19.46%	Sales Q/Q	8.93%	Earnings	Apr 30 BMO	Avg Volume	1.90M	Price	53.10
SMA20	0.53%	SMA50	-4.56%	SMA200	-9.61%	Trades		Volume	1,060,059	Change	-0.75%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-23-24	Initiated	Cantor Fitzgerald	Neutral
Feb-23-24	Initiated	Jefferies	Buy	$81
Feb-14-24	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Dec-13-23	Upgrade	Leerink Partners	Market Perform → Outperform	$78
Dec-04-23	Upgrade	Guggenheim	Neutral → Buy	$86
Nov-21-23	Downgrade	Goldman	Buy → Neutral	$98 → $65
Jul-25-23	Initiated	Citigroup	Buy	$82
May-04-23	Downgrade	BofA Securities	Buy → Neutral	$84
Apr-10-23	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$81 → $79
Mar-24-23	Upgrade	SVB Securities	Underperform → Market Perform	$61
Jan-31-23	Initiated	Piper Sandler	Overweight	$100
Aug-03-22	Downgrade	Guggenheim	Buy → Neutral
Aug-03-22	Downgrade	Evercore ISI	Outperform → In-line	$90 → $78
Jul-28-22	Initiated	Wells Fargo	Equal Weight	$76
Feb-09-22	Downgrade	SVB Leerink	Mkt Perform → Underperform	$60 → $56
Jan-18-22	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$78 → $90
Nov-19-21	Initiated	BMO Capital Markets	Market Perform	$75
Jul-20-21	Upgrade	The Benchmark Company	Hold → Buy	$89
Feb-10-21	Downgrade	SVB Leerink	Mkt Perform → Underperform	$70
Jan-07-21	Initiated	Truist	Buy	$120

Show Previous Ratings

Today 03:17PM	MacroGenics, Inc. (NASDAQ:MGNX) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-09-24 06:15AM	The 3 Best Biotech Stocks to Buy in May 2024 (InvestorPlace)
May-02-24 11:17PM	Q1 2024 Insight Enterprises Inc Earnings Call (Thomson Reuters StreetEvents)
08:00AM	Incyte to Present at Upcoming Investor Conference (Business Wire)
May-01-24 11:24AM	TD Cowen Adjusts Price Target on Incyte to $80 From $88 (MT Newswires)
11:12AM	Loading…
11:12AM	Incyte Corporation (NASDAQ:INCY) Q1 2024 Earnings Call Transcript (Insider Monkey)
10:53AM	RBC Capital Adjusts Price Target on Incyte to $60 From $65 (MT Newswires)
10:33AM	Piper Sandler Adjusts Price Target on Incyte to $80 From $85 (MT Newswires)
10:20AM	Goldman Sachs Adjusts Price Target on Incyte to $60 From $63 (MT Newswires)
08:55AM	Leerink Partners Adjusts Price Target on Incyte to $80 From $83, Keeps Outperform Rating (MT Newswires)
07:58AM	Citigroup Adjusts Price Target on Incyte to $80 From $81 (MT Newswires)
07:50AM	BMO Capital Adjusts Incyte Price Target to $52 From $56 (MT Newswires)
Apr-30-24 04:31PM	Analyst Report: Incyte Corporation (Morningstar Research)
02:57PM	Truist Securities Trims Incyte's Price Target to $83 From $84, Buy Rating Maintained (MT Newswires)
11:54AM	INCY Stock Earnings: Incyte Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
11:50AM	Loading…
11:50AM	Incyte's (INCY) Q1 Earnings & Revenues Fall Shy of Estimates (Zacks)
10:10AM	Incyte misses quarterly profit on weak sales of lead drug (Reuters)
09:36AM	Incyte's Q1 Non-GAAP Earnings, Revenue Rise; 2024 Guidance Reaffirmed (MT Newswires)
09:30AM	Incyte (INCY) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
08:34AM	Incyte Corp (INCY) Q1 2024 Earnings: Misses Revenue Estimates but Shows Strong Growth in ... (GuruFocus.com)
07:10AM	Incyte: Q1 Earnings Snapshot (Associated Press Finance)
07:00AM	Incyte Reports 2024 First Quarter Financial Results and Provides Updates on Key Clinical Programs (Business Wire)
Apr-23-24 10:12AM	Incyte, fresh off gaining MorphoSys drug, buys Escient for $750M (FierceBiotech.com)
10:01AM	Incyte (INCY) Earnings Expected to Grow: Should You Buy? (Zacks)
09:44AM	Incyte (INCY) to Report Q1 Earnings: What's in the Cards? (Zacks)
07:00AM	Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists (Business Wire)
Apr-15-24 05:30AM	Certain Biotech Investors Get an Early Look at Results. Is That Fair? (The Wall Street Journal)
Apr-11-24 08:00AM	Incyte to Report First Quarter Financial Results (Business Wire)
Apr-06-24 08:56AM	Biotech Executive Who Bet on Rivals Stock Committed Insider Trading, Jury Says (The Wall Street Journal)
Apr-01-24 08:30AM	Incyte and CMS Announce Collaboration and License Agreement for Povorcitinib, an Oral JAK1 Inhibitor, in Mainland China, Hong Kong, Macau, Taiwan and Southeast Asia (Business Wire)
08:30AM	Loading…
08:30AM	CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia (GlobeNewswire)
Mar-31-24 11:53AM	12 Best S&P 500 Stocks To Buy According to Analysts (Insider Monkey)
Mar-29-24 04:30PM	Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Mar-26-24 02:47PM	SEC Tests Insider-Trading Theory at Trial of Ex-Biotech Executive (Bloomberg)
Mar-17-24 08:50AM	30 Biggest Biotechnology Companies in the World (Insider Monkey)
Mar-15-24 10:37AM	MorphoSys AG (NASDAQ:MOR) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-14-24 11:30AM	Why Is Incyte (INCY) Up 1.8% Since Last Earnings Report? (Zacks)
08:18AM	MacroGenics, Inc. (NASDAQ:MGNX) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-12-24 01:52PM	Incyte (INCY) Posts Positive Results on Opzelura From HS Study (Zacks)
Mar-11-24 01:02PM	Penny Stock Detox: 3 Stocks to Buy for Multibagger Returns Instead (InvestorPlace)
07:18AM	Incyte, itching for a piece of Dupixent's market, hits goals in midphase skin disease trial (FierceBiotech.com)
Mar-10-24 04:05PM	Incyte Presents New Late-Breaking Data from Phase 2 Study Evaluating Povorcitinib in Patients with Prurigo Nodularis (Business Wire)
04:05PM	Incyte Announces New Data from Phase 2 Study Evaluating Ruxolitinib Cream (Opzelura) in Patients with Mild-to-Moderate Hidradenitis Suppurativa (Business Wire)
Mar-07-24 03:00PM	3 Cancer-Fighting Biotech Stocks Showing Clinical Trial Promise (InvestorPlace)
Mar-04-24 08:00AM	New Data from Incytes Growing Dermatology Portfolio to be Presented at the 2024 American Academy of Dermatology (AAD) Annual Meeting (Business Wire)
Mar-03-24 08:29AM	Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-29-24 10:19AM	Incyte Launches The Unseen Journey to Elevate the Hidden Impact of Myeloproliferative Neoplasms (MPNs) on Patients Lives through Generative AI (Business Wire)
07:30AM	Knight Therapeutics Announces Launch of Minjuvi in Brazil (GlobeNewswire)
Feb-28-24 01:10PM	Q4 2023 Syndax Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-27-24 04:08PM	Incyte Announces U.S. Food and Drug Administration Grants Priority Review for Axatilimab for the Treatment of Chronic Graft-Versus-Host Disease (Business Wire)
Feb-26-24 03:20PM	7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff (InvestorPlace)
Feb-21-24 04:50PM	Exit Now! 3 Biotech Stocks to Sell in February 2024 (InvestorPlace)
Feb-15-24 08:00AM	Incyte to Present at Upcoming Investor Conference (Business Wire)
Feb-14-24 09:32AM	Incyte Corporation (NASDAQ:INCY) Q4 2023 Earnings Call Transcript (Insider Monkey)
01:15AM	Q4 2023 Incyte Corp Earnings Call (Thomson Reuters StreetEvents)
12:12AM	Decoding Incyte Corp (INCY): A Strategic SWOT Insight (GuruFocus.com)
Feb-13-24 05:43PM	Analyst Report: Incyte Corporation (Morningstar Research)
11:37AM	Incyte's (INCY) Q4 Earnings & Revenues Fall Shy of Estimates (Zacks)
09:30AM	Here's What Key Metrics Tell Us About Incyte (INCY) Q4 Earnings (Zacks)
08:26AM	Incyte misses quarterly profit estimates due to higher costs (Reuters)
08:25AM	Incyte (INCY) Lags Q4 Earnings and Revenue Estimates (Zacks)
07:38AM	Incyte Corp (INCY) Reports Solid Growth in 2023, Sets Sights on Future Pipeline Expansion (GuruFocus.com)
07:35AM	Incyte Q4 Adj EPS Misses Estimates, But Revenues Top (RTT News)
07:34AM	Incyte: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	Incyte Reports 2023 Fourth Quarter and Year-End Financial Results, Provides 2024 Financial Guidance and Highlights R&D Priorities (Business Wire)
Feb-09-24 11:03AM	Incyte (INCY) to Report Q4 Earnings: What's in the Cards? (Zacks)
09:15AM	Ahead of Incyte (INCY) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics (Zacks)
Feb-07-24 08:55AM	Pancreatic Cancer Treatments Poised for Major Advances in 2024 (PR Newswire)
Feb-06-24 04:30AM	MorphoSys to sell to Novartis for $2.9B, offload cancer drug to Incyte (BioPharma Dive)
Feb-05-24 06:54PM	Biotech Stock MorphoSys Catapults 56% As Novartis Agrees To Buy It For $2.9 Billion (Investor's Business Daily)
04:46PM	Incyte Gains Exclusive Global Development and Commercialization Rights to Tafasitamab (Monjuvi) (Business Wire)
Jan-31-24 07:33PM	Analyst Report: Incyte Corporation (Morningstar Research)
Jan-30-24 11:07AM	Agilent, Incyte to partner on companion diagnostics (MedTech Dive)
Jan-26-24 09:12AM	Incyte (INCY) Banks on Opzelura as Jakafi Faces Competition (Zacks)
Jan-24-24 08:39AM	Incyte vets, with phase 1 within reach, raise $102M for new biotech to create better PARP, PI3K drugs (FierceBiotech.com)
Jan-23-24 08:00AM	Incyte to Report Fourth Quarter and Year-End 2023 Financial Results (Business Wire)
Jan-18-24 04:00PM	3 Pharma Stocks Could Be the Pills Your Portfolio Needs (InvestorPlace)
Jan-08-24 08:30AM	Incyte Highlights Growth Opportunities and Provides Business Updates at the 42nd Annual J.P. Morgan Healthcare Conference (Business Wire)
Jan-06-24 11:02AM	EVP & Chief Medical Officer Steven Stein Sells Shares of Incyte Corp (INCY) (GuruFocus.com)
Jan-02-24 07:19PM	Analyst Report: Incyte Corporation (Morningstar Research)
Dec-20-23 01:50PM	12 Most Promising Gene Editing Stocks According to Hedge Funds (Insider Monkey)
Dec-19-23 11:41AM	13 Most Promising Healthcare Stocks According to Analysts (Insider Monkey)
Dec-15-23 02:30PM	The 3 Most Undervalued Biotech Stocks to Buy in December (InvestorPlace)
Dec-12-23 12:46PM	Incyte Stock Is the S&P 500s Top Performer. Heres Why Its Surging. (Barrons.com) +8.45%
08:00AM	Incyte to Present at Upcoming Investor Conferences (Business Wire)
Dec-10-23 05:00PM	Incyte and Syndax Present Additional Data from Positive AGAVE-201 Trial at ASH Plenary Session Showing Axatilimab Efficacy Including Durable Responses in Chronic Graft-Versus-Host Disease (Business Wire)
Dec-05-23 10:32AM	Incyte's Bullish Outlook: A Surprising Strength You Shouldn't Overlook (GuruFocus.com)
Nov-30-23 11:31AM	Why Is Incyte (INCY) Down 1.8% Since Last Earnings Report? (Zacks)
Nov-16-23 12:17PM	5 Best Debt Free Stocks To Buy (Insider Monkey)
Nov-13-23 09:50PM	Jim Simons Stock Portfolio: 12 Biggest Healthcare Stocks (Insider Monkey)
Nov-12-23 08:18AM	3 Biotech Stocks That Are Poised to Have Breakthroughs in 2024 (InvestorPlace)
Nov-09-23 10:01PM	7 Underappreciated Biotech Stocks to Pick Up on the Cheap (InvestorPlace)
Nov-02-23 09:00AM	Incyte to Spotlight More Than 40 Hematology and Oncology Abstracts Including a Plenary Presentation at the ASH Annual Meeting (Business Wire)
Nov-01-23 12:32PM	Incyte Corporation (NASDAQ:INCY) Q3 2023 Earnings Call Transcript (Insider Monkey)
Oct-31-23 09:52PM	Analyst Report: Incyte Corporation (Morningstar Research)
12:14PM	Incyte (INCY) Beats on Q3 Earnings, Misses Revenue Estimates (Zacks)
09:36AM	Drugmaker Incyte's quarterly profit beats on lower costs (Reuters)
09:30AM	Incyte (INCY) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
08:43AM	Incyte Corp (INCY) Reports 12% Y/Y Increase in Q3'23 Total Revenues (GuruFocus.com)
08:15AM	Incyte (INCY) Surpasses Q3 Earnings Estimates (Zacks)

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded in April 1991 and is headquartered in Wilmington, DE.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BAKER BROS. ADVISORS LP	Director	May 07 '24	Option Exercise	49.01	30,000	1,470,300	33,462,981	May 09 06:25 PM
Stein Steven H	EVP & Chief Medical Officer	Jan 03 '24	Sale	65.51	7,365	482,481	90,218	Jan 05 12:27 PM
Iyengar Vijay K	EVP, GMAPPS	Jan 02 '24	Sale	65.00	657	42,705	43,412	Jan 04 01:05 PM
Tray Thomas	Principal Accounting Officer	Dec 13 '23	Sale	62.37	1,067	66,549	23,436	Dec 14 02:11 PM
Tray Thomas	Principal Accounting Officer	Dec 12 '23	Sale	57.36	210	12,046	24,503	Dec 14 02:11 PM
SWAIN PAULA J	EVP, Human Resources	Sep 01 '23	Sale	65.13	8,449	550,283	77,530	Sep 06 04:00 PM
Stein Steven H	EVP & Chief Medical Officer	Aug 01 '23	Sale	63.28	21,511	1,361,216	97,583	Aug 03 04:00 PM

Open in Screener

LOPE

Grand Canyon Education Inc

May 10 • 03:50PM ET

149.21

Dollar change -0.05
Percentage change -0.03	%

Consumer Defensive • Education & Training Services • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

LOPE Grand Canyon Education Inc daily Stock Chart

Held by: IJH VTI VB VXF VBK XMHQ IJK SCHA FNDA DFAS

Index	-	P/E	20.85	EPS (ttm)	7.16	Insider Own	2.17%	Shs Outstand	29.95M	Perf Week	9.62%
Market Cap	4.44B	Forward P/E	17.15	EPS next Y	8.70	Insider Trans	-0.45%	Shs Float	29.14M	Perf Month	12.90%
Income	213.43M	PEG	-	EPS next Q	1.10	Inst Own	94.97%	Short Float	1.45%	Perf Quarter	11.73%
Sales	985.45M	P/S	4.51	EPS this Y	11.46%	Inst Trans	0.50%	Short Ratio	2.31	Perf Half Y	10.00%
Book/sh	25.45	P/B	5.86	EPS next Y	10.88%	ROA	22.35%	Short Interest	0.42M	Perf Year	36.28%
Cash/sh	9.76	P/C	15.29	EPS next 5Y	-	ROE	30.09%	52W Range	99.65 - 156.56	Perf YTD	13.00%
Dividend Est.	-	P/FCF	20.13	EPS past 5Y	7.53%	ROI	25.25%	52W High	-4.69%	Beta	0.65
Dividend TTM	-	Quick Ratio	2.78	Sales past 5Y	2.76%	Gross Margin	51.62%	52W Low	49.73%	ATR (14)	3.61
Dividend Ex-Date	-	Current Ratio	2.78	EPS Y/Y TTM	19.32%	Oper. Margin	26.31%	RSI (14)	80.08	Volatility	3.24% 2.30%
Employees	5800	Debt/Eq	0.13	Sales Y/Y TTM	7.43%	Profit Margin	21.66%	Recom	1.33	Target Price	158.33
Option/Short	Yes / Yes	LT Debt/Eq	0.11	EPS Q/Q	18.03%	Payout	0.00%	Rel Volume	1.09	Prev Close	149.26
Sales Surprise	0.83%	EPS Surprise	5.68%	Sales Q/Q	9.82%	Earnings	May 07 AMC	Avg Volume	182.24K	Price	149.21
SMA20	11.92%	SMA50	11.74%	SMA200	17.88%	Trades		Volume	193,416	Change	-0.03%

Date	Action	Analyst	Rating Change	Price Target Change
May-03-23	Reiterated	Barrington Research	Outperform	$130 → $140
Jan-28-22	Downgrade	Berenberg	Buy → Hold	$110 → $86
Oct-20-20	Initiated	Berenberg	Buy
Sep-11-20	Upgrade	Sidoti	Neutral → Buy	$114
Jun-11-20	Initiated	Sidoti	Neutral
Nov-09-18	Reiterated	Barrington Research	Outperform	$135 → $150
Jul-03-18	Reiterated	Piper Jaffray	Overweight	$117 → $142
Nov-02-17	Reiterated	Barrington Research	Outperform	$98 → $103
Oct-11-17	Reiterated	Piper Jaffray	Overweight	$83 → $92
Aug-02-17	Reiterated	Barrington Research	Outperform	$85 → $89
May-08-17	Reiterated	Barrington Research	Outperform	$68 → $85
Feb-17-17	Reiterated	Barrington Research	Outperform	$66 → $68
Aug-05-16	Reiterated	Piper Jaffray	Overweight	$49 → $53
Mar-07-16	Upgrade	Credit Suisse	Neutral → Outperform
Feb-03-16	Initiated	Credit Suisse	Neutral
Aug-11-15	Reiterated	Barrington Research	Outperform	$55 → $50
Oct-15-14	Upgrade	Robert W. Baird	Neutral → Outperform	$47 → $47
Aug-04-14	Reiterated	CRT Capital	Buy	$63 → $65.50
May-01-14	Reiterated	Stifel	Buy	$49 → $51
Jan-30-14	Initiated	CRT Capital	Buy	$63

Show Previous Ratings

May-09-24 12:00PM	Grand Canyon Education (LOPE) is a Great Momentum Stock: Should You Buy? (Zacks)
09:15AM	Grand Canyon Education, Inc. (LOPE) Hit a 52 Week High, Can the Run Continue? (Zacks)
08:50AM	Here's Why Momentum in Grand Canyon Education (LOPE) Should Keep going (Zacks)
May-08-24 12:17PM	Grand Canyon Education, Inc. (NASDAQ:LOPE) Q1 2024 Earnings Call Transcript (Insider Monkey) +5.22%
12:05PM	Baird Adjusts Price Target on Grand Canyon Education to $170 From $165, Keeps Outperform Rating (MT Newswires)
04:36AM	Loading…
04:36AM	Grand Canyon Education Q1 Adjusted Profit, Revenue Rise; Updates Guidance (MT Newswires)
03:50AM	Grand Canyon Education Inc (LOPE) (Q1 2024) Earnings Call Transcript Highlights: Strong ... (GuruFocus.com)
May-07-24 06:00PM	Grand Canyon Education (LOPE) Q1 Earnings and Revenues Top Estimates (Zacks)
05:50PM	Grand Canyon Education Inc. (LOPE) Q1 2024 Earnings: Surpasses Revenue Forecasts (GuruFocus.com)
04:57PM	Grand Canyon Education: Q1 Earnings Snapshot (Associated Press Finance)
04:39PM	Grand Canyon Education's (NASDAQ:LOPE) Q1: Beats On Revenue (StockStory)
04:05PM	GRAND CANYON EDUCATION, INC. REPORTS FIRST QUARTER 2024 RESULTS (PR Newswire)
May-06-24 03:05AM	Grand Canyon Education (LOPE) Q1 Earnings Report Preview: What To Look For (StockStory)
Apr-18-24 03:35AM	A Look Back at Education Services Stocks' Q4 Earnings: Lincoln Educational (NASDAQ:LINC) Vs The Rest Of The Pack (StockStory)
Apr-16-24 04:15PM	Grand Canyon Education, Inc. Announces First Quarter 2024 Earnings Release Date and Conference Call Details (PR Newswire)
05:54AM	Loading…
05:54AM	Education Services Stocks Q4 Highlights: Grand Canyon Education (NASDAQ:LOPE) (StockStory)
Apr-15-24 04:08AM	Education Services Stocks Q4 In Review: Laureate Education (NASDAQ:LAUR) Vs Peers (StockStory)
Apr-09-24 06:19AM	Education Services Stocks Q4 Highlights: Strategic Education (NASDAQ:STRA) (StockStory)
Apr-01-24 03:41PM	Grand Canyon Teachs How To Recruit 100K-Plus Students, Gets Key Rating Upgrade (Investor's Business Daily)
Mar-30-24 11:37PM	15 Cheapest Universities with Low Tuition Fees for International Students in Europe (Insider Monkey)
Mar-28-24 05:07AM	Q4 Earnings Highlights: Perdoceo Education (NASDAQ:PRDO) Vs The Rest Of The Education Services Stocks (StockStory)
Mar-19-24 07:00PM	Insider Sell: Chief Technology Officer Dilek Marsh Sells Shares of Grand Canyon Education Inc (LOPE) (GuruFocus.com)
Mar-11-24 09:00AM	ARIZONA VA AGENCY FINDS NO WRONGDOING IN AUDIT OF GRAND CANYON UNIVERSITY (PR Newswire)
Mar-05-24 06:10PM	Grand Canyon Stock Rising Toward Fresh All-Time High (Investor's Business Daily)
Feb-28-24 10:21AM	5 Best Education Stocks To Buy In 2024 (Insider Monkey)
Feb-14-24 11:00AM	GRAND CANYON UNIVERSITY HONORS LEADERS WITH THE FOURTH ANNUAL COLANGELO SERVANT LEADERSHIP AWARDS (PR Newswire)
09:04AM	Grand Canyon Education, Inc. (NASDAQ:LOPE) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-13-24 05:20PM	Grand Canyon Education (LOPE) Q4 Earnings and Revenues Top Estimates (Zacks)
04:42PM	Grand Canyon Education Inc (LOPE) Reports Solid Q4 and Year-End Financials for 2023 (GuruFocus.com)
04:32PM	Grand Canyon Education: Q4 Earnings Snapshot (Associated Press Finance)
04:12PM	Loading…
04:12PM	Grand Canyon Education's (NASDAQ:LOPE) Q4 Sales Beat Estimates, (StockStory)
04:05PM	GRAND CANYON EDUCATION, INC. REPORTS FOURTH QUARTER 2023 RESULTS (PR Newswire)
Feb-12-24 02:00AM	What To Expect From Grand Canyon Educations (LOPE) Q4 Earnings (StockStory)
Jan-23-24 07:20PM	Grand Canyon Education, Inc. Investors: Company Investigated by the Portnoy Law Firm (GlobeNewswire)
Jan-17-24 12:17PM	3 Stocks at the Forefront of the Remote Learning Revolution (InvestorPlace)
Jan-10-24 02:15PM	Grand Canyon Education, Inc. Announces Fourth Quarter 2023 Earnings Release Date and Conference Call Details (PR Newswire)
Jan-05-24 10:59AM	FEDERAL GOVERNMENT CONTINUES ATTACK WITH YET ANOTHER INQUIRY VS. GCU (PR Newswire)
Jan-01-24 07:36PM	Grand Canyon Education, Inc: Company Investigated by the Portnoy Law Firm (GlobeNewswire)
Dec-29-23 04:42PM	These Stocks Moved the Most Today: Lyft, Uber, Alphabet, Boeing, Fisker, and More (Barrons.com)
01:33PM	These Stocks Are Moving the Most Today: Lyft, Uber, Alphabet, Boeing, Fisker, and More (Barrons.com)
Dec-28-23 08:01AM	3 Charts For Investors to Watch Thursday: GC Education, Iovance, Ethereum (Investopedia) -6.36%
Dec-27-23 05:05PM	UPDATE 2-US FTC sues Grand Canyon University for deceptive advertising, illegal telemarketing (Reuters)
03:40PM	US FTC sues Grand Canyon University for deceptive advertising, illegal telemarketing (Reuters)
Dec-22-23 02:11PM	25 Smartest States with the Highest Average IQ (Insider Monkey)
Dec-14-23 10:00AM	GRAND CANYON UNIVERSITY EXTENDS TUITION FREEZE FOR 16th CONSECUTIVE YEAR (PR Newswire)
Dec-12-23 08:50AM	Grand Canyon Education (LOPE) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
Nov-24-23 09:40AM	Is Grand Canyon Education (LOPE) Stock Outpacing Its Consumer Discretionary Peers This Year? (Zacks)
08:50AM	Recent Price Trend in Grand Canyon Education (LOPE) is Your Friend, Here's Why (Zacks)
Nov-21-23 12:11PM	17 Countries With The Best Education In Europe (Insider Monkey)
05:04AM	Insider Sell: Director Jack Henry Sells Shares of Grand Canyon Education Inc (LOPE) (GuruFocus.com)
Nov-16-23 12:00PM	GRAND CANYON UNIVERSITY APPEALS UNPRECEDENTED DECISION, RECORD FINE FROM U.S. DEPARTMENT OF EDUCATION (PR Newswire)
Nov-08-23 08:50AM	Grand Canyon Education (LOPE) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks)
Nov-03-23 11:11AM	Grand Canyon Education, Inc. (NASDAQ:LOPE) Q3 2023 Earnings Call Transcript (Insider Monkey) +12.54%
Nov-02-23 06:45PM	Grand Canyon Education Inc (LOPE) Reports Q3 2023 Results: Net Income Rises to $35.7 Million (GuruFocus.com)
05:36PM	Grand Canyon Education: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	GRAND CANYON EDUCATION, INC. REPORTS THIRD QUARTER 2023 RESULTS (PR Newswire)
Oct-27-23 11:40AM	LRN vs. LOPE: Which Stock Is the Better Value Option? (Zacks)
Oct-24-23 02:26PM	Use New Analyst Coverage to Buy Great Stocks During Q3 Earnings Season (Zacks)
Oct-12-23 08:09AM	Zacks Industry Outlook Highlights Bright Horizons Family Solutions, Grand Canyon Education, Strategic Education, Adtalem Global Education and American Public Education (Zacks)
Oct-11-23 11:55AM	5 Stocks in the Booming Schools Industry for Enhanced Returns (Zacks)
Oct-06-23 11:40AM	ATGE or LOPE: Which Is the Better Value Stock Right Now? (Zacks)
Oct-03-23 04:15PM	Grand Canyon Education, Inc. Announces Third Quarter 2023 Earnings Release Date and Conference Call Details (PR Newswire)
08:00AM	Grand Canyon Education Inc: A Deep Dive into Its Intrinsic Value (GuruFocus.com)
Sep-28-23 07:00AM	Grand Canyon Stock Forms Symmetric Pattern; Ready To Break Out? (Investor's Business Daily)
Sep-01-23 11:40AM	PRDO vs. LOPE: Which Stock Is the Better Value Option? (Zacks)
Aug-30-23 12:09PM	Grand Canyon (LOPE) Expects More Than 14% Enrollment in 2023 (Zacks)
Aug-28-23 11:00AM	GRAND CANYON UNIVERSITY EXPECTING RECORD ENROLLMENT (PR Newswire)
Aug-08-23 03:03PM	BlackRock Inc. Acquires Additional Shares in Grand Canyon Education Inc. (GuruFocus.com)
Aug-03-23 07:25PM	Grand Canyon Education (LOPE) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
06:17PM	Grand Canyon Education: Q2 Earnings Snapshot (AP Finance)
Jul-24-23 05:00AM	Zacks Industry Outlook Highlights PowerSchool, Grand Canyon Education, Adtalem Global and American Public Education (Zacks)
Jul-21-23 11:40AM	AFYA vs. LOPE: Which Stock Is the Better Value Option? (Zacks)
11:35AM	4 Stocks From a Buoyant Schools Industry for Higher Returns (Zacks)
Jul-11-23 09:00AM	Grand Canyon Education, Inc. Announces Second Quarter 2023 Earnings Release Date and Conference Call Details (PR Newswire)
Jul-05-23 11:40AM	AFYA or LOPE: Which Is the Better Value Stock Right Now? (Zacks)
Jun-21-23 08:00PM	LOPE: Lowering target price to $112.00 (Argus Research)
Jun-19-23 09:00AM	Scoop Up These 4 GARP Stocks to Receive Handsome Returns (Zacks)
Jun-05-23 10:16AM	4 GARP Stocks to Scoop Up for Maximum Returns (Zacks)
Jun-02-23 09:35AM	Grand Canyon Education (LOPE) Loses -8.11% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Jun-01-23 09:35AM	Grand Canyon Education (LOPE) Loses -9.36% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
May-27-23 09:09AM	Grand Canyon Education's (NASDAQ:LOPE) earnings growth rate lags the 17% return delivered to shareholders (Simply Wall St.)
May-22-23 11:40AM	ATGE or LOPE: Which Is the Better Value Stock Right Now? (Zacks)
May-19-23 08:01AM	Zacks.com featured highlights include W.W. Grainger, Hubbell, Allegion and Grand Canyon Education (Zacks)
May-18-23 09:19AM	Scoop Up These 4 GARP Stocks to Receive Handsome Returns (Zacks)
May-12-23 06:29AM	Zacks Industry Outlook Highlights Grand Canyon Education, Adtalem Global Education, Stride and Perdoceo Education (Zacks)
May-11-23 11:33AM	4 Stocks From a Buoyant Schools Industry to Buy for Higher Returns (Zacks)
May-05-23 11:40AM	ATGE vs. LOPE: Which Stock Is the Better Value Option? (Zacks)
May-04-23 09:15AM	Grand Canyon Education, Inc. (LOPE) Hits Fresh High: Is There Still Room to Run? (Zacks)
08:50AM	Here's Why Momentum in Grand Canyon Education (LOPE) Should Keep going (Zacks)
May-02-23 05:35PM	Grand Canyon Education (LOPE) Q1 Earnings and Revenues Surpass Estimates (Zacks)
04:05PM	GRAND CANYON EDUCATION, INC. REPORTS FIRST QUARTER 2023 RESULTS (PR Newswire)
07:19AM	Estimating The Intrinsic Value Of Grand Canyon Education, Inc. (NASDAQ:LOPE) (Simply Wall St.)
Apr-26-23 08:00PM	LOPE: Lowering target price to $121.00 (Argus Research)
Apr-25-23 06:05PM	K12 (LRN) Q3 Earnings and Revenues Beat Estimates (Zacks)
Apr-19-23 11:40AM	PRDO or LOPE: Which Is the Better Value Stock Right Now? (Zacks)
Apr-14-23 10:49AM	10 Best Education Stocks To Buy In 2023 (Insider Monkey)
Apr-11-23 11:56AM	Grand Canyon Education (NASDAQ:LOPE) Is Very Good At Capital Allocation (Simply Wall St.)
Apr-10-23 04:30PM	Grand Canyon Education, Inc. Announces First Quarter 2023 Earnings Release Date and Conference Call Details (PR Newswire)
Apr-03-23 08:50AM	Grand Canyon Education (LOPE) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
Mar-30-23 08:26AM	Heres Why Grand Canyon Education (LOPE) Became Diamond Hill Long-Short Funds Bottom Contributor (Insider Monkey)

Grand Canyon Education, Inc. engages in the provision of education services. It offers graduate and undergraduate degree programs and certificates across colleges. The company was founded by Christopher C. Richardson and Brent D. Richardson in November 2003 and is headquartered in Phoenix, AZ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Marsh Dilek	CHIEF TECHNOLOGY OFFICER	Mar 18 '24	Sale	132.65	1,500	198,975	25,674	Mar 19 04:15 PM
HENRY JACK A	Director	Nov 17 '23	Sale	137.92	1,450	199,984	14,782	Nov 20 04:30 PM
Keegan Lisa Graham	Director	Aug 10 '23	Sale	109.34	540	59,044	2,905	Aug 10 06:55 PM
Browning Lori	Chief Accounting Officer	Aug 08 '23	Sale	112.75	2,500	281,875	13,663	Aug 08 04:32 PM
HENRY JACK A	Director	May 23 '23	Sale	109.53	2,500	273,825	15,493	May 25 04:32 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

INCY

Incyte Corp.

LOPE

Grand Canyon Education Inc

Upgrade your FINVIZ experience